Innoviva - 9 Year Dividend History | INVA

Historical dividend payout and yield for Innoviva (INVA) since 2016. The current TTM dividend payout for Innoviva (INVA) as of June 11, 2025 is $0.00. The current dividend yield for Innoviva as of June 11, 2025 is 0.00%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $1.342B $0.359B
Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $766.349B 58.76
Johnson & Johnson (JNJ) United States $373.567B 15.45
AbbVie (ABBV) United States $338.266B 18.65
Roche Holding AG (RHHBY) Switzerland $262.069B 0.00
Novartis AG (NVS) Switzerland $249.414B 14.24
Merck (MRK) United States $201.686B 10.31
Pfizer (PFE) United States $139.178B 7.63
Sanofi (SNY) France $121.887B 12.01
Bayer (BAYRY) Germany $31.241B 6.36
Novo Nordisk (NVO) Denmark $0.000B 23.29